bpc-157 human evidence randomized trial and the Difference Between an Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. β WellFounded ππ»ββοΈ Is the lack of
Description
In addition, there was a lower incidence of nephropathy and a non-significantly higher incidence of retinopathy ( p = 0.33) in the liraglutide group in LEADER
Improperly stored BPC-157 can degrade losing bioactivity, changing purity, and producing inconsistent research results

In his level chart of 1-28, this rates in at a 36

Changes in retinal morphology are seen in response to 10 and 100 g/L BPS 40,41 , 3 mg/L BPS 39 , and 2.8 mg/L BPA 25
It is a synthetic short peptide bioregulator modeled on the natural pineal peptide complex, developed within Vladimir Khavinsons program

Ive only been on it for almost 1 month and Ive lost 9 pounds